Stay informed with the latest updates for the inheritable blood disorders community. Industry CSL Behring Announces Product Donations to WFHMar 15, 2015 Industry Octapharma Announces Co-Pay Assistance for WilateMar 10, 2015 Industry Bayer Submits Application for Investigational Recombinant Factor VIII…Mar 9, 2015 Industry Baxter Reports Gene Therapy Program UpdatesFeb 20, 2015 Industry OPKO Health Submits Application to FDA for Long-Acting Factor VIIaFeb 11, 2015 Industry Biogen Idec and TIGET to Collaborate on Gene TherapyFeb 11, 2015 Industry Enroll Now in HCV Clinical Trial for People with HemophiliaOct 7, 2014 Industry Grifols Announces Larger Vial Size for ALPHANATE®Sep 29, 2014 Industry FDA Approves Baxter’s RIXUBIS for Children with Hemophilia BSep 25, 2014 Industry Researchers Report Advances in Plant-based Hemophilia A TherapySep 10, 2014 Industry Expression and ABL to Develop and Market High-Yield, Low-Cost rFVIIISep 3, 2014 Industry Achillion’s New HCV Treatment Performing Well in Phase 2 TrialSep 3, 2014 Industry BAX 855 Performs Well Prophylactically in Phase 3 TrialAug 25, 2014 Industry BeneFIX® Performs Well in Prophylaxis TrialJul 28, 2014 Industry FDA Approves Octagam® 10% for Chronic ITPJul 23, 2014 Pagination First page Previous page … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page Last page
